Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Magnasco

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Opinion in Infectious Diseases|February 19, 2020
Role of new antibiotics in the treatment of acute bacterial skin and skin-structure infectionsMatteo Bassetti, Laura Magnasco, Filippo Del Puente, et al.
Expert Opinion on Investigational Drugs|April 4, 2020
Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant <i>Staphylococcus aureus</i>: advances in phase I and II trialsMatteo Bassetti, Filippo Del Puente, Laura Magnasco, et al.
Current Opinion in Infectious Diseases|February 7, 2022
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?Matteo Bassetti, Laura Magnasco, Antonio Vena, et al.
Seminars in Respiratory and Critical Care Medicine|February 1, 2024
Antibiotic Strategies for Severe Community-Acquired PneumoniaMatteo Bassetti, Daniele R Giacobbe, Laura Magnasco, et al.
Polymers|March 28, 2026
A Sustainable Path for Automotive Composite Tooling: Novel Materials, Design, and Technologies Through FEM and LCAGloria Anna Carallo, Laura Magnasco, Stefano Chiocca, et al.
Expert Opinion on Pharmacotherapy|December 22, 2022
Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infection: what are the challenges?Antonio Vena, Nadia Castaldo, Laura Magnasco, et al.
Expert Review of Clinical Pharmacology|June 28, 2021
Recent advances and future perspectives in the pharmacological treatment of <i>Candida auris</i> infectionsDaniele R Giacobbe, Laura Magnasco, Chiara Sepulcri, et al.
Frontiers in Bioscience (Landmark Edition)|September 30, 2021
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenarioDaniele Roberto Giacobbe, Lorenzo Ball, Laura Magnasco, et al.
Journal of Fungi (Basel, Switzerland)|February 25, 2025
Species-Specific Sensitivity and Levels of Beta-D-Glucan for the Diagnosis of Candidemia-A Systematic Review and Meta-AnalysisNadir Ullah, Marco Muccio, Laura Magnasco, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2022
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary studyMalgorzata Mikulska, Elisa Furfaro, Laura Magnasco, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Opinion in Infectious Diseases|February 19, 2020
Role of new antibiotics in the treatment of acute bacterial skin and skin-structure infectionsMatteo Bassetti, Laura Magnasco, Filippo Del Puente, et al.
Expert Opinion on Investigational Drugs|April 4, 2020
Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant <i>Staphylococcus aureus</i>: advances in phase I and II trialsMatteo Bassetti, Filippo Del Puente, Laura Magnasco, et al.
Current Opinion in Infectious Diseases|February 7, 2022
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?Matteo Bassetti, Laura Magnasco, Antonio Vena, et al.
Seminars in Respiratory and Critical Care Medicine|February 1, 2024
Antibiotic Strategies for Severe Community-Acquired PneumoniaMatteo Bassetti, Daniele R Giacobbe, Laura Magnasco, et al.
Polymers|March 28, 2026
A Sustainable Path for Automotive Composite Tooling: Novel Materials, Design, and Technologies Through FEM and LCAGloria Anna Carallo, Laura Magnasco, Stefano Chiocca, et al.
Expert Opinion on Pharmacotherapy|December 22, 2022
Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infection: what are the challenges?Antonio Vena, Nadia Castaldo, Laura Magnasco, et al.
Expert Review of Clinical Pharmacology|June 28, 2021
Recent advances and future perspectives in the pharmacological treatment of <i>Candida auris</i> infectionsDaniele R Giacobbe, Laura Magnasco, Chiara Sepulcri, et al.
Frontiers in Bioscience (Landmark Edition)|September 30, 2021
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenarioDaniele Roberto Giacobbe, Lorenzo Ball, Laura Magnasco, et al.
Journal of Fungi (Basel, Switzerland)|February 25, 2025
Species-Specific Sensitivity and Levels of Beta-D-Glucan for the Diagnosis of Candidemia-A Systematic Review and Meta-AnalysisNadir Ullah, Marco Muccio, Laura Magnasco, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2022
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary studyMalgorzata Mikulska, Elisa Furfaro, Laura Magnasco, et al.
Pageof 6